Search results - 5 results
Characterisation of tetanus monoclonal antibodies as a first step towards the development of an in vitro vaccine potency immunoassay.
in these products is of utmost importance for product safety and clinical effect. Immunochemical methods that measure consistency of antigen content and quality, potentially as an indicator of potency, ...
Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation.
for most vaccines not performed. At the Belgian Scientific institute of public health, MPL content is determined for batch release of a human papilloma virus vaccine and a hepatitis B vaccine. Testing ...
Cloning of the gene encoding a 22-kilodalton cell surface antigen of Mycobacterium bovis BCG and analysis of its potential for DNA vaccination against tuberculosis.
Publication Type: Peer reviewed scientific article Authors: Lefèvre, P; Denis, O; De Wit, L; Tanghe, A; Vandenbussche, P; Content, J; Huygen, K Source: Infect Immun, Volume 68, Issue 3, Number 1047, ...
Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.
Publication Type: Peer reviewed scientific article Authors: Lozes, E; Huygen, K; Content, J; Denis, O; Montgomery, D L; Yawman, A M; Vandenbussche, P; Van Vooren, J P; Drowart, A; Ulmer, J B; Liu, ...
Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.
relationship between antigenicity and immunogenicity of sIPV is not well understood. METHODS: A collaborative study was conducted in which laboratories used different methods to measure the antigen content of ...